Celerion

Celerion is a global leader in early clinical research and Applied Translational Medicine, helping biopharmaceutical companies translate scientific discoveries into actionable insights that support drug development and clinical decision-making.

With more than 50 years of experience and a global network of clinical research facilities, including over 600 clinic beds and in-hospital capabilities, Celerion specializes in First-in-Human studies, clinical proof-of-concept trials, cardiovascular safety assessments, ADME studies, and NDA-enabling clinical pharmacology research.

The company provides comprehensive support across the drug development lifecycle, including clinical study design, modeling and simulation, biostatistics, clinical data sciences, medical writing, PK/PD analysis, and bioanalytical services for both small and large molecules. Celerion also offers regulatory, drug development, and program management expertise to help clients accelerate development timelines and make informed decisions throughout the clinical research process.

By combining scientific expertise, advanced analytical capabilities, and extensive clinical research experience, Celerion helps bring innovative therapies from discovery to patients more efficiently and effectively.